Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Erin Henderson

Onconetix, Inc. reported in an 8-K filed January 19, 2024 that Erin Henderson resigned as Chief Business Officer, effective December 21, 2023. Onconetix, Inc. reported in an 8-K filed December 28, 2023 that Erin Henderson resigned as Chief Business Officer, effective December 21, 2023. The proxy statement of Onconetix, Inc. reports total compensation of $550,972 for Erin Henderson in fiscal 2023, including a base salary of $315,972. Disclosed compensation is on record for 4 fiscal years.

“As previously reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission on December 28, 2023, Erin Henderson resigned as Chief Business Officer of Onconetix, Inc. (the "Company"), effective as of December 21, 2023.”
Onconetix, Inc. Form 8-K, filed January 19, 2024 · Read the filing
“On and effective December 21, 2023, Erin Henderson resigned as Chief Business Officer of Onconetix, Inc. (the "Company") to pursue other opportunities.”
Onconetix, Inc. Form 8-K, filed December 28, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Onconetix, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Onconetix, Inc. (ONCO) $315,972 $550,972
2022 Onconetix, Inc. (ONCO) $296,905 $1,233,354
2021 Onconetix, Inc. (ONCO) $120,000 $171,173
2020 Onconetix, Inc. (ONCO) $80,849 $112,384

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.